{"filing":{"accession_number":"0001609550-26-000038","cik":"0001609550","ticker":"INSP","company_name":"Inspire Medical Systems, Inc.","form":"8-K","filing_date":"2026-07-22","report_date":null,"primary_document":"insp-20260716.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1609550/000160955026000038/insp-20260716.htm"},"events":[{"id":19352,"run_id":17413,"accession_number":"0001609550-26-000038","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Casey Tansey, a Board member of 18+ years and early venture investor who led Inspire's Series A financing in 2007, notified the Company on July 16, 2026 of his decision to retire from the Board effective July 30, 2026. The Item 5.02 disclosure centers on his departure from the Board and decision not to stand for re-election, with no compensatory arrangements or new appointments disclosed. This is a material departure of a long-tenured director with significant historical influence on the company.","company_name":"Inspire Medical Systems, Inc.","ticker":"INSP","filing_date":"2026-07-22","form":"8-K","submitted_at":null,"items":[{"id":18422,"accession_number":"0001609550-26-000038","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Casey Tansey, a Board member of 18+ years and early venture investor who led Inspire's Series A financing in 2007, notified the Company on July 16, 2026 of his decision to retire from the Board effective July 30, 2026. The Item 5.02 disclosure centers on his departure from the Board and decision not to stand for re-election, with no compensatory arrangements or new appointments disclosed. This is a material departure of a long-tenured director with significant historical influence on the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T12:03:37.525316+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18422,"accession_number":"0001609550-26-000038","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Casey Tansey, a Board member of 18+ years and early venture investor who led Inspire's Series A financing in 2007, notified the Company on July 16, 2026 of his decision to retire from the Board effective July 30, 2026. The Item 5.02 disclosure centers on his departure from the Board and decision not to stand for re-election, with no compensatory arrangements or new appointments disclosed. This is a material departure of a long-tenured director with significant historical influence on the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T12:03:37.525316+00:00","company_name":"Inspire Medical Systems, Inc.","ticker":"INSP","filing_date":"2026-07-22"}]}